Clinical Trial Update: Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effect of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Cyclosporin (cyclosporine)
• Sodium Zirconium Cyclosilicate (sodium zirconium cyclosilate)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia | Phase 1 | Status: COMPLETED | Results posted: 2024-04-05